Orthofix Appoints Julie Dewey as Chief Investor Relations and Communications Officer

Orthofix has appointed Julie Dewey as its new chief investor relations and communications officer. Max Reinhardt has also begun as president of the company’s global spine business.
 
Dewey had roles as a corporate officer for multiple publicly traded medical device companies. She was most recently chief communications and investor relations officer at Treace Medical Concepts. Earlier in her career, she was the senior VP and chief medical officer at Wright Medical, which was acquired by Stryker in 2020.
 
According to the company, Dewey is renowned for her focus on IR program development positioning medtech companies in the financial market, and expanding outreach and engagement with investors.
 
“I am thrilled to join Orthofix in this new leadership role at such a transformational time in its growth trajectory,” said Dewey. “I look forward to working with Massimo and the rest of the Orthofix team to execute on the company’s growth strategy and deliver a best-in-class experience for the investment community and key stakeholders.”
 
“We are excited to welcome Julie to the company,” said Orthofix president and CEO Massimo Calafiore. “She is deeply respected within the industry and brings with her vast knowledge of our markets, technologies, and growth strategies. Her appointment not only strengthens our executive leadership team, but it also further establishes our focus on expanding our outreach with investors and analysts as we continue to drive profitability and growth for our shareholders.”